Published in Infect Immun on February 03, 2014
Preterm birth, intrauterine infection, and fetal inflammation. Front Immunol (2014) 0.91
Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update. Clin Perinatol (2015) 0.76
The Human Ureaplasma Species as Causative Agents of Chorioamnionitis. Clin Microbiol Rev (2016) 0.75
Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides. Pharmaceuticals (Basel) (2016) 0.75
Pulmonary vascular changes in extremely preterm sheep after intra-amniotic exposure to Ureaplasma parvum and lipopolysaccharide. PLoS One (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol (2006) 3.41
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol (2009) 3.40
Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol (2006) 2.95
qPrimerDepot: a primer database for quantitative real time PCR. Nucleic Acids Res (2006) 2.31
Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol (2008) 2.28
Histone modifications induced by a family of bacterial toxins. Proc Natl Acad Sci U S A (2007) 1.86
Histone modifications and chromatin remodeling during bacterial infections. Cell Host Microbe (2008) 1.67
Human defensins and LL-37 in mucosal immunity. J Leukoc Biol (2009) 1.67
The roles of antimicrobial peptides in innate host defense. Curr Pharm Des (2009) 1.58
Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Semin Fetal Neonatal Med (2008) 1.34
Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp. Int J Antimicrob Agents (2011) 1.30
Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Pathog (2009) 1.28
Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence. Pediatr Res (2009) 1.21
Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains. BMC Microbiol (2012) 1.21
Effect of natural amphipathic peptides on viability, membrane potential, cell shape and motility of mollicutes. Res Microbiol (1997) 1.20
Antimicrobial proteins and polypeptides in pulmonary innate defence. Respir Res (2006) 1.18
Ureaplasma infection and neonatal lung disease. Semin Perinatol (2007) 1.18
Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures. Antimicrob Agents Chemother (2002) 1.17
Different inflammatory responses are associated with Ureaplasma parvum-induced UTI and urolith formation. BMC Infect Dis (2009) 1.14
Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults. Infect Immun (2001) 1.13
Sodium butyrate up-regulates cathelicidin gene expression via activator protein-1 and histone acetylation at the promoter region in a human lung epithelial cell line, EBC-1. Mol Immunol (2006) 1.10
Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes. J Clin Microbiol (2011) 1.07
CyProQuant-PCR: a real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use. BMC Immunol (2005) 1.06
A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts. J Microbiol Methods (2005) 1.05
Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States. Antimicrob Agents Chemother (2012) 1.05
Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line. Int J Antimicrob Agents (2002) 1.03
Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression. J Immunol (2008) 0.97
Chronic fetal exposure to Ureaplasma parvum suppresses innate immune responses in sheep. J Immunol (2011) 0.97
Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis. Antimicrob Agents Chemother (2006) 0.95
Haplotyping and copy number estimation of the highly polymorphic human beta-defensin locus on 8p23 by 454 amplicon sequencing. BMC Genomics (2010) 0.93
Depressed cellular immunity in Mycoplasma pneumoniae pneumonia. Eur J Respir Dis (1987) 0.92
In vitro antimicrobial inhibition of Mycoplasma bovis isolates submitted to the Pennsylvania Animal Diagnostic Laboratory using flow cytometry and a broth microdilution method. J Vet Diagn Invest (2011) 0.92
Effect of induced expression of an antimicrobial peptide melittin on Chlamydia trachomatis and Mycoplasma hominis infections in vivo. Biochem Biophys Res Commun (2005) 0.90
Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide. Dev Comp Immunol (2007) 0.89
Humoral and cellular immunity in children with Mycoplasma pneumoniae infection: a 1-year prospective study. Clin Diagn Lab Immunol (2005) 0.87
Effect of progesterone on proinflammatory cytokine production by monocytes stimulated with pathogens associated with preterm birth. Am J Reprod Immunol (2008) 0.85
Antimicrobial activity of inducible human beta defensin-2 against Mycoplasma pneumoniae. Curr Microbiol (2006) 0.81
Induced expression of the antimicrobial peptide melittin inhibits experimental infection by Mycoplasma gallisepticum in chickens. Microbes Infect (2004) 0.81
Maximin 9, a novel free thiol containing antimicrobial peptide with antimycoplasma activity from frog Bombina maxima. FEBS Lett (2005) 0.80
Molecular cloning and characterization of three beta-defensins from canine testes. Infect Immun (2005) 0.80
Antimicrobial activity and molecular mechanism of the CRES protein. PLoS One (2012) 0.79
Host defense peptides: an alternative as antiinfective and immunomodulatory therapeutics. Biopolymers (2012) 0.79
Application of flow cytometry for the determination of minimal inhibitory concentration of several antibacterial agents on Mycoplasma hyopneumoniae. J Appl Microbiol (2007) 0.78
Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima. Biochem Biophys Res Commun (2005) 0.78
Global suppression of mitogen-activated ovine peripheral blood mononuclear cells by surface protein activity from Mycoplasma ovipneumoniae. Vet Immunol Immunopathol (2010) 0.78
Use of flow cytometry for enumeration of Mycoplasma mycoides subsp. mycoides large-colony type in broth medium. J Appl Microbiol (2006) 0.77
Evaluation of Mycoplasma hyopneumoniae growth by flow cytometry. J Appl Microbiol (2005) 0.77
Recombinant plasmid constructs expressing gene for antimicrobial peptide melittin for the therapy of Mycoplasma and chlamydia infections. Bull Exp Biol Med (2007) 0.76
Flow cytometric method for quantifying viable Mycoplasma agassizii, an agent of upper respiratory tract disease in the desert tortoise (Gopherus agassizii). Lett Appl Microbiol (2010) 0.76
The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med (2015) 4.49
Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother (2003) 4.29
Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature (2002) 4.21
Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev (2008) 3.20
New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol (2008) 2.00
Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies. J Clin Microbiol (2005) 1.79
Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates. J Clin Microbiol (2006) 1.71
Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. Pediatr Infect Dis J (2009) 1.62
Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants. Pediatr Res (2011) 1.60
In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother (2003) 1.53
SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J (2009) 1.41
Trends in new injuries, prevalent cases, and aging with spinal cord injury. Arch Phys Med Rehabil (2011) 1.41
Macrolide-Resistant Mycoplasma pneumoniae, United States. Emerg Infect Dis (2015) 1.36
Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J (2005) 1.33
Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp. Int J Antimicrob Agents (2011) 1.30
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib. BMC Med Genet (2007) 1.28
Detection and characterization of human Ureaplasma species and serovars by real-time PCR. J Clin Microbiol (2010) 1.28
Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae. Emerg Infect Dis (2005) 1.26
Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J Clin Invest (2012) 1.22
Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains. BMC Microbiol (2012) 1.21
Ureaplasma infection and neonatal lung disease. Semin Perinatol (2007) 1.18
SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J Biol Chem (2010) 1.16
Aerobic exercise attenuates airway inflammatory responses in a mouse model of atopic asthma. J Immunol (2004) 1.16
Bacillus cereus bacteremia in a preterm neonate. J Clin Microbiol (2003) 1.13
Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis. Neoplasia (2008) 1.13
The role of Mycoplasma in upper respiratory infections. Curr Infect Dis Rep (2009) 1.12
Functional neurological recovery after spinal cord injury is impaired in patients with infections. Brain (2012) 1.11
Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. EMBO J (2010) 1.11
Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia. J Clin Microbiol (2005) 1.10
Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes. J Clin Microbiol (2011) 1.07
Sore Throat: Avoid Overcomplicating the Uncomplicated. Ann Intern Med (2015) 1.07
Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States. Antimicrob Agents Chemother (2012) 1.05
Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia. Pediatr Infect Dis J (2011) 1.05
Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder. J Spinal Cord Med (2006) 1.03
Fall-induced spinal cord injury: External causes and implications for prevention. J Spinal Cord Med (2015) 1.02
Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms. Microbiology (2013) 1.00
In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas. Antimicrob Agents Chemother (2003) 1.00
Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. Am J Obstet Gynecol (2012) 1.00
Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America. J Clin Microbiol (2003) 1.00
USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections. J Clin Microbiol (2007) 1.00
Mycoplasma pneumoniae Infections in Childhood. Pediatr Infect Dis J (2014) 0.98
Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center. J Clin Microbiol (2006) 0.97
Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother (2003) 0.96
Oral and nasal sensitization promote distinct immune responses and lung reactivity in a mouse model of peanut allergy. Am J Pathol (2005) 0.94
Body mass index underestimates adiposity in women with spinal cord injury. Obesity (Silver Spring) (2013) 0.93
Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep (2014) 0.93
Do communities matter after rehabilitation? The effect of socioeconomic and urban stratification on well-being after spinal cord injury. Arch Phys Med Rehabil (2011) 0.93
Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia. J Clin Pharmacol (2010) 0.92
The use of a biodegradable, load-bearing scaffold as a carrier for antibiotics in an infected open fracture model. J Orthop Trauma (2010) 0.92
Bactericidal activity of levofloxacin against Mycoplasma pneumoniae. J Antimicrob Chemother (2003) 0.90
Transplacental transfer of Azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model. J Infect Dis (2013) 0.90
Nosocomial ventriculitis due to Roseomonas gilardii complicating subarachnoid haemorrhage. J Infect (2005) 0.90
Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura. J Pediatr (2009) 0.90
Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae. PLoS One (2010) 0.90
Detection of Mycoplasma pneumoniae in simulated and true clinical throat swab specimens by nanorod array-surface-enhanced Raman spectroscopy. PLoS One (2010) 0.89
SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in an Sp1-dependent manner. Biochem J (2011) 0.89
Induction of a late asthmatic response associated with airway inflammation in mice. Eur J Pharmacol (2005) 0.89
In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials. Int J Antimicrob Agents (2002) 0.88
Identification of an alternatively spliced isoform of the fyn tyrosine kinase. Biochem Biophys Res Commun (2002) 0.88
Dissemination of community-associated methicillin-resistant Staphylococcus aureus in a tertiary care hospital. South Med J (2008) 0.88
Comparison of the illumigene Mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae. J Clin Microbiol (2014) 0.88
Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol (2002) 0.87
Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor kappaB are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent. Free Radic Biol Med (2006) 0.86
Deficient immune response to Mycoplasma pneumoniae in childhood asthma. Allergy Asthma Proc (2009) 0.86
Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae. Int J Antimicrob Agents (2003) 0.86
Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a Veterans Affairs Medical Center. Infect Control Hosp Epidemiol (2008) 0.86
Stromal regulation of human gastric dendritic cells restricts the Th1 response to Helicobacter pylori. Gastroenterology (2011) 0.86
Genotype-phenotype correlations emerging from the identification of missense mutations in MBTPS2. Hum Mutat (2013) 0.85
A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells. Microb Pathog (2005) 0.85
Phosphorylated insulin-like growth factor 1 receptor is implicated in resistance to the cytostatic effect of gefitinib in colorectal cancer cells. J Gastrointest Surg (2011) 0.85
Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose. Antimicrob Agents Chemother (2013) 0.84
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother (2008) 0.84
Geographic variation in participation for physically disabled adults: the contribution of area economic factors to employment after spinal cord injury. Soc Sci Med (2012) 0.83
Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression. Oncol Rep (2011) 0.83
Activation-induced changes in alternate splice acceptor site usage. Biochem Biophys Res Commun (2007) 0.81
Activity and participation after spinal cord injury: state-of-the-art report. J Rehabil Res Dev (2012) 0.81
Clinical observation on YiSuiShengXueGranule on treating 156 patients with beta-thalassemia major and the molecular mechanism study. Biol Pharm Bull (2007) 0.80
Autografts and xenografts of skin fibroblasts delivering BMP-2 effectively promote orthotopic and ectopic osteogenesis. Anat Rec (Hoboken) (2009) 0.80
Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection. Vaccine (2005) 0.80
The E-cadherin (CDH1) -C160A polymorphism and colorectal cancer susceptibility: a meta-analysis. DNA Cell Biol (2012) 0.80
Feasibility of exercising adults with asthma: a randomized pilot study. Allergy Asthma Clin Immunol (2012) 0.79
Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother (2005) 0.79
Comparison of Molecular Characteristics of Mycoplasma pneumoniae Specimens Collected from the United States and China. J Clin Microbiol (2015) 0.79
Helicobacter pylori infection inhibits phagocyte clearance of apoptotic gastric epithelial cells. J Immunol (2013) 0.79
Mycoplasma edwardii peritonitis in a patient on maintenance peritoneal dialysis. Clin Nephrol (2015) 0.79
Fusobacterium necrophorum bacteremic tonsillitis: 2 Cases and a review of the literature. Anaerobe (2010) 0.78
Pulmonary aneurysms and intracardiac thrombi due to Behçet's disease in an African-American adolescent with oculocutaneous albinism. Clin Rheumatol (2006) 0.78